Approval · Notice of Compliance 20915 · 2018
VISKAZIDE: Notice of Compliance 20915
Issued May 30, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20915
- Date
- May 30, 2018
- Company
- Aralez Pharmaceuticals Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 25 MG per TAB
- PINDOLOL 10 MG per TAB
- HYDROCHLOROTHIAZIDE 50 MG per TAB